查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1808578

神經設備市場（按產品、應用、最終用戶和分銷管道）—2025-2030 年全球預測

Neurology Devices Market by Product, Application, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

神經系統設備市場預計到 2024 年將達到 127.4 億美元，2025 年將達到 139.6 億美元，到 2030 年將達到 228 億美元，複合年成長率為 10.18%。

主要市場統計數據
基準年2024年 127.4億美元
預計2025年 139.6億美元
預測年份 2030 228億美元
複合年成長率（%） 10.18%

探索在技術快速發展和監管變化的時代塑造先進神經病學設備的不斷發展的創新和挑戰

神經醫學醫療設備領域正處於關鍵的十字路口，技術突破和臨床實踐的轉變正在迅速改變患者的治療通訊協定。隨著精準醫療的發展，設備開發商正在整合先進的感測器、人工智慧和先進材料，以根據患者獨特的神經生理特徵提供客製化治療方案。越來越多的臨床證據表明，治療效果得到改善，不利事件減少，進一步推動了個人化治療的發展。

新興技術、臨床模式轉移和跨學科整合如何重新定義神經病學設備開發和患者照護途徑

多學科協作和以患者為中心的設計理念正在推動一波變革，重塑神經病學設備格局。神經影像學和術中導航的快速發展使微創手術成為新的治療標準，縮短了手術時間並加快了患者康復。同時，植入式神經調節系統的廣泛應用正在重新定義從慢性疼痛到神經退化性疾病等各種疾病的治療模式，其封閉回路型回饋機制提高了療效和安全性。

評估 2025 年美國關稅對神經醫學醫療設備供應鏈、成本結構和競爭動態的整體影響

2025年美國關稅的實施為神經病學設備生態系統帶來了巨大的阻力，影響了價值鏈的各個環節。面對進口零件關稅的提高，製造商必須重新評估籌資策略，一些製造商將部分生產轉移到更靠近終端市場的地方，以減輕成本影響。雖然這種向近岸外包的轉變降低了供應鏈的脆弱性，但也需要對國內基礎設施進行大量的資本投資。

發現產品、應用、最終用戶和分銷管道的關鍵細分模式，以推動策略性神經醫學醫療設備決策

關鍵細分市場分析揭示了推動應用和投資的細微促進因素，並突顯了臨床和商業重點的交會點。評估產品格局表明，涵蓋腦脊髓液管理設備（例如神經外科引流和腦分流術）以及介入性神經病學工具（包括動脈瘤栓塞和栓塞術、球囊血管成形術和支架、神經血栓切除術和神經血管導管）的技術各自都呈現出獨特的創新需求。動脈瘤栓塞和栓塞術強調了栓塞圈、血流轉向裝置和液體栓塞劑在降低復發率方面的作用，而腦球囊血管成形術和支架置入術策略則著重於最佳化球囊閉塞、頸動脈支架和過濾裝置的設備配置。同樣，神經血栓切除術的演變凸顯了血栓移除裝置、勒除器器和真空抽吸系統的發展；而神經刺激領域的不斷擴展則涵蓋了深部腦部刺激、胃電刺激、薦椎神經刺激、脊髓刺激和迷走神經刺激。最後，動脈瘤夾、神經科學用內視鏡、立體定位系統和超音波吸引器等神經外科設備的進步，凸顯了人們對精準和微創治療的持續追求。

分析影響美國、歐洲、中東和非洲以及亞太地區神經病學設備採用路徑的機會和挑戰

區域動態在塑造神經病學設備市場的發展軌跡方面發揮著重要作用，因為多樣化的醫療基礎設施、報銷框架和患者人口統計都會影響採用率。美洲地區憑藉其成熟的學術醫療中心網路和良好的數位療法法規環境，已迅速普及先進的監測和神經調節系統。然而，成本控制壓力以及向基於價值的醫療模式的轉變，正在加強對長期臨床效益的審查。

分析關鍵參與者和創新者，以發現神經醫學醫療設備領域的策略聯盟、創新路徑和競爭優勢

主要企業和新興創新者正透過策略聯盟、定向研發投入以及整合護理模式的構建，樹立新的標竿。老字型大小企業正在深化與學術中心的合作，共同開發融合先進感測和自適應演算法的下一代神經刺激平台。同時，新創公司正在開拓生物電子學和軟體機器人技術，展示成功的概念驗證，並吸引許可和收購的興趣。

產業領導者的策略藍圖，旨在應對監管複雜性、利用技術進步並加強其在醫療設備領域的地位

產業領導者必須採取前瞻性策略，使研發重點與不斷發展的臨床和監管模式保持一致。企業應優先開發能夠支援多種適應症的平台技術，以最大限度地提高投資收益並促進跨職能協同效應。對強大的數據分析和遠端監控能力的投資將增強真實世界證據的產生。

結合初步訪談、二次資料分析和統計檢驗的綜合研究途徑確保對神經病學設備有深入的了解

本研究採用多階段方法，確保研究結論的完整性和有效性。主要資料收集包括與關鍵意見領袖（包括神經科、介入放射科醫生和設備工程師）進行結構化訪談，以掌握未滿足需求和創新瓶頸的第一手觀點。次要研究資訊來源包括監管資料庫、臨床試驗註冊中心和同行評審文獻，以揭示產品平臺和核准趨勢。

綜合關鍵發現和策略重點，確定神經醫學醫療設備領域的未來方向和投資機會

快速的技術進步、不斷變化的報銷模式以及日益複雜的監管環境定義了神經醫學醫療設備領域的格局。透過分析，我們可以清楚地看到，那些整合數位智慧、深化策略夥伴關係並保持敏捷製造地的公司將會獲得成功。透過閉合迴路神經調節和微創干預實現的個人化治療將推動下一波臨床突破。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 用於持續家庭癲癇監測的人工智慧可攜式腦電圖穿戴式設備的成長和整合
  • 封閉回路型深部腦部刺激裝置的進展為巴金森氏症的治療提供了適應性療法
  • 非侵入性經顱磁刺激裝置在難治性重度憂鬱症治療的應用日益增多
  • 推出可與智慧型手機連接、用於緩解慢性神經病變疼痛的植入式無線神經刺激系統
  • 用於癱瘓復健即時腦機介面控制的高密度皮質內電極陣列的開發
  • 擴展小型穿戴式近紅外光譜設備，用於中風復健計畫中的非侵入性監測

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第 8 章神經系統設備市場（按產品）

  • 腦脊髓液管理裝置
    • 腦外引流
    • 腦分流術
  • 介入性神經病學
    • 動脈瘤線圈栓塞術
      • 栓塞線圈
      • 導流裝置
      • 液態栓塞試劑
    • 腦球囊血管成形術和支架
      • 球囊封堵器
      • 頸動脈支架
      • 過濾裝置
    • 神經血栓切除術
      • 血塊回收器
      • 勒除器裝置
      • 吸力吸引裝置
    • 神經血管導管
  • 神經刺激
    • 深部腦部刺激
    • 胃電刺激
    • 薦椎神經刺激
    • 脊髓刺激
    • 迷走神經刺激
  • 神經外科設備
    • 動脈瘤夾
    • 神經科學用內視鏡
    • 立體定位放射系統
    • 超音波吸引器

第9章 神經設備市場（按應用）

  • 慢性疼痛
  • 癲癇和癲癇發作
    • 癲癇的診斷和監測
    • 癲癇抑制裝置
  • 精神疾病
    • 焦慮
    • 憂鬱症
    • 思覺失調症
  • 多發性硬化症（MS）
  • 神經退化性疾病
    • 阿茲海默症
    • 肌萎縮側索硬化症（ALS）
    • 亨丁頓舞蹈症
    • 帕金森氏症
  • 神經血管疾病
  • 脊髓損傷
  • 中風
    • 出血性中風裝置
    • 缺血性中風設備
    • 中風復健設備
  • 創傷性腦損傷（TBI）

第 10 章 神經設備市場（依最終用戶）

  • 學術研究機構
  • 診斷中心
  • 居家護理
  • 醫院
  • 神經科診所
  • 復健中心

第 11 章神經系統設備市場（依通路）

  • 離線
  • 線上

第 12 章：美洲神經設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第 13 章：歐洲、中東和非洲的神經設備市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

第 14 章：亞太神經設備市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第15章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • Acandis GmbH
    • B. Braun SE
    • Boston Scientific Corporation
    • Esaote SpA
    • GE HealthCare Technologies, Inc.
    • Integra LifeSciences Holdings
    • Koninklijke Philips NV
    • Masimo Corporation
    • Medtronic PLC
    • MicroPort Scientific Corporation
    • Natus Medical Inc.
    • Nihon Kohden Corporation
    • Penumbra Inc.
    • Rapid Medical Ltd.
    • Siemens Healthcare GmbH
    • Stryker Corporation
    • Terumo Corporation

第16章 研究人工智慧

第17章 研究統計

第18章 研究聯絡人

第19章 研究報導

第20章 附錄

Product Code: MRR-F6513A06BEEC

The Neurology Devices Market was valued at USD 12.74 billion in 2024 and is projected to grow to USD 13.96 billion in 2025, with a CAGR of 10.18%, reaching USD 22.80 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 12.74 billion
Estimated Year [2025] USD 13.96 billion
Forecast Year [2030] USD 22.80 billion
CAGR (%) 10.18%

Discover the Unfolding Innovations and Challenges Shaping Advanced Neurology Devices in an Era of Rapid Technological Evolution and Regulatory Shifts

The field of neurology devices stands at a pivotal juncture, where breakthroughs in technology and shifts in clinical practice are rapidly altering patient care protocols. As precision medicine gains momentum, device developers are integrating sophisticated sensors, artificial intelligence, and advanced materials to deliver tailored therapies that align with the unique neurophysiological profiles of patients. This drive toward personalization is fueled by a growing body of clinical evidence demonstrating improved outcomes and reduced adverse events.

Regulatory landscapes are also evolving, with agencies worldwide emphasizing post-market surveillance, cybersecurity standards, and streamlined pathways for digital therapeutics. At the same time, healthcare providers are under mounting pressure to demonstrate value, leading to increased collaboration between device manufacturers, payers, and clinical networks. Against this backdrop, a clear understanding of the interplay between innovation, regulation, and market access has never been more critical for stakeholders seeking to navigate complexity and capitalize on emerging opportunities.

How Emerging Technologies, Clinical Paradigm Shifts, and Cross-Disciplinary Integration Are Redefining Neurology Device Development and Patient Care Pathways

A wave of transformative shifts is reshaping the neurology devices landscape, driven by cross-disciplinary convergence and patient-centric design philosophies. Rapid advances in neuroimaging and intraoperative navigation have enabled minimally invasive interventions to become the new standard of care, reducing procedure times and accelerating recovery. In parallel, the proliferation of implantable neuromodulation systems is redefining therapeutic paradigms for conditions ranging from chronic pain to neurodegenerative disorders, with closed-loop feedback mechanisms enhancing efficacy and safety.

Meanwhile, the integration of machine learning algorithms into diagnostic platforms is unlocking predictive capabilities that were previously unattainable. This is complemented by the emergence of digital biomarkers, which harness wearable sensors and remote monitoring to capture rich datasets in real time. As industry players forge partnerships with technology innovators and academic centers, new business models are taking shape that prioritize outcome-based agreements and digital services alongside traditional capital equipment. Consequently, stakeholders must remain agile, anticipating how these converging trends will dictate the next frontier of clinical performance and commercial success.

Assessing the Aggregate Consequences of 2025 United States Tariffs on Neurology Device Supply Chains, Cost Structures, and Competitive Dynamics

The implementation of United States tariffs in 2025 has introduced significant headwinds for the neurology devices ecosystem, affecting every stage of the value chain. Manufacturers facing elevated duties on imported components have had to reassess sourcing strategies, with some relocating portions of production closer to end markets to mitigate cost impacts. This shift toward nearshoring has alleviated certain supply chain vulnerabilities, yet it has also necessitated substantial capital investment in domestic infrastructure.

On the demand side, hospitals and clinics are increasingly scrutinizing total cost of ownership, compelling device suppliers to justify price adjustments with demonstrable clinical and operational benefits. In response, vendors are accelerating innovation cycles, embedding connectivity features that support remote diagnostics and predictive maintenance to counterbalance tariff-induced price pressures. At the same time, collaborative consortia are emerging to share best practices in procurement and logistics, reinforcing resilience against future trade policy fluctuations. As a result, companies that proactively adapt their manufacturing footprint and value propositions are better positioned to sustain growth in this new trade environment.

Unveiling Key Segmentation Patterns Across Products, Applications, End Users, and Distribution Channels That Drive Strategic Decision Making in Neurology Devices

Critical segmentation analysis reveals nuanced drivers of adoption and investment, highlighting where clinical and commercial priorities intersect. When evaluating the product landscape, it becomes evident that technologies spanning CSF Management Devices-such as cerebral external drainage and cerebral shunts-and Interventional Neurology tools for aneurysm coiling and embolization, balloon angioplasty & stents, neurothromboectomy, and neurovascular catheters each present distinct innovation imperatives. Within aneurysm coiling and embolization, embolic coils, flow diversion devices, and liquid embolic reagents command attention for their role in reducing recurrence rates, while cerebral balloon angioplasty & stents strategies focus on optimizing device profiles for balloon occlusion, carotid artery stents, and filter devices. Equally, the evolution of neurothromboectomy highlights clot retrievers, snare devices, and suction aspiration systems, and the expanding realm of neurostimulation encompasses deep brain stimulation, gastric electric stimulation, sacral nerve stimulation, spinal cord stimulation, and vagus nerve stimulation. Finally, advances in neurosurgery devices like aneurysm clips, neuroendoscopes, stereotactic systems, and ultrasonic aspirators underscore the ongoing push toward precision and minimal invasiveness.

Similarly, application-based segmentation underscores the varying unmet needs across therapeutic areas. In chronic pain management, the emphasis is on long-term safety and patient comfort, whereas epilepsy & seizure disorders demand robust solutions for diagnosis & monitoring of epilepsy and seizure control devices. Treatment pathways for mental health disorders-including anxiety, depression, and schizophrenia-are evolving with neurostimulation and closed-loop monitoring, and multiple sclerosis strategies must accommodate both relapsing and progressive forms. Neurodegenerative disorder profiles span Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and Parkinson's disease, each requiring distinct device capabilities. Neurovascular disorders present acute intervention challenges, spinal cord injuries call for regenerative and assistive technologies, and stroke care differentiates between hemorrhagic stroke devices, ischemic stroke devices, and stroke rehabilitation devices. Traumatic brain injury remains a high-priority area for intracranial pressure management and neurorehabilitation.

On the end-user front, the ecosystem stretches from academic & research institutes and diagnostic centers to home care, hospitals, neurology clinics, and rehabilitation centers, each setting imposing unique training, reimbursement, and integration requirements. Distribution channels, whether offline or online, further shape go-to-market strategies, impacting everything from product demonstrations to post-sales support.

Analyzing Regional Opportunities and Challenges in the Americas, Europe Middle East Africa, and Asia Pacific That Shape Neurology Device Adoption Pathways

Regional dynamics play an outsized role in shaping the trajectory of neurology device markets, as diverse healthcare infrastructures, reimbursement frameworks, and patient demographics influence adoption rates. In the Americas, a well-established network of academic medical centers and a favorable regulatory climate for digital therapeutics support rapid uptake of advanced monitoring and neuromodulation systems. Yet cost containment pressures and shifts toward value-based care models are driving heightened scrutiny of long-term clinical benefits.

Europe Middle East Africa embodies a mosaic of markets where regulatory harmonization under evolving directives intersects with national payer negotiations. This environment creates both barriers and opportunities for device innovators, particularly those leveraging real-world evidence to substantiate outcomes. Growing investments in neurovascular centers of excellence are enhancing the profile of interventional neurology and stroke rehabilitation technologies.

In Asia Pacific, dynamic growth is underpinned by expanding healthcare budgets, rising incidence of neurological disorders, and government initiatives to bolster domestic manufacturing capabilities. Local partnerships and licensing agreements have become essential pathways for global manufacturers seeking to navigate diverse regulatory landscapes and accelerate market entry. Consequently, stakeholders must adopt differentiated regional strategies that account for local standards, reimbursement pathways, and clinician training requirements.

Profiling Leading Players and Innovators to Highlight Strategic Collaborations, Innovation Pathways, and Competitive Differentiators in Neurology Devices

Leading players and rising innovators are establishing new benchmarks through strategic collaborations, targeted research and development investments, and the creation of integrated care models. Established firms are deepening partnerships with academic centers to co-develop next-generation neurostimulation platforms that incorporate advanced sensing and adaptive algorithms. Concurrently, venture-backed startups are pioneering bioelectronics and soft robotics, demonstrating proof-of-concept successes that are attracting licensing and acquisition interest.

Partnerships between device manufacturers and digital health providers are expanding the scope of remote patient management, with cross-industry alliances enabling the incorporation of cloud-based analytics and telemedicine workflows. Patent portfolios and regulatory approvals serve as key differentiators, and companies that maintain a balanced mix of incremental enhancements and disruptive breakthroughs are consistently outperforming peers in clinical acceptance. As M&A activity accelerates in areas such as minimally invasive interventional neurology and closed-loop neuromodulation, market leadership hinges on the ability to integrate complementary assets and scale solutions across global markets.

Strategic Roadmap for Industry Leaders to Navigate Regulatory Complexities, Capitalize on Technological Advances, and Strengthen Position in Neurology Devices

Industry leaders must adopt a forward-looking strategy that aligns R&D priorities with evolving clinical and regulatory paradigms. Companies should prioritize the development of platform technologies capable of supporting multiple indications, thereby maximizing return on investment and facilitating cross-functional synergies. Investing in robust data analytics and remote monitoring capabilities will enhance real-world evidence generation, which is increasingly vital for securing favorable reimbursement and payer contracts.

At the same time, regional supply chain diversification and nearshoring initiatives should be advanced to buffer against future trade policy disruptions. Engaging early with regulatory agencies on digital health guidelines and post-market surveillance expectations can streamline approval pathways and minimize time to market. Finally, forging collaborative ecosystems with healthcare providers, technology firms, and patient advocacy groups will accelerate adoption and ensure that product roadmaps remain closely aligned with unmet clinical needs.

Comprehensive Research Approach Combining Primary Interviews, Secondary Data Analysis, and Statistical Validation to Ensure Robust Insights in Neurology Devices

This research employs a multi-phased approach to ensure the integrity and relevance of insights. Primary data collection involved structured interviews with key opinion leaders, including neurologists, interventional radiologists, and device engineers, to capture firsthand perspectives on unmet needs and innovation bottlenecks. Secondary research sources encompassed regulatory databases, clinical trial registries, and peer-reviewed literature to contextualize product pipelines and approval trends.

Quantitative analysis was conducted using a rigorous data triangulation framework that reconciled manufacturer disclosures, hospital procurement records, and publicly available financial reports. Statistical validation techniques were applied to identify significant trends and correlations. An expert advisory board reviewed intermediate findings to refine assumptions and interpret emerging themes, thereby ensuring that the final deliverables reflect both empirical evidence and real-world clinical practice.

Synthesizing Key Findings and Strategic Imperatives to Illuminate Future Directions and Investment Opportunities in the Neurology Devices Landscape

The neurology devices landscape is defined by rapid technological advancement, shifting reimbursement models, and increasingly complex regulatory frameworks. Through this analysis, it is clear that success will favor organizations that integrate digital intelligence, deepen strategic partnerships, and maintain agile manufacturing footprints. Personalization of therapies through closed-loop neuromodulation and minimally invasive interventions is set to drive the next wave of clinical breakthroughs.

Looking forward, industry players that invest in scalable platform technologies and robust evidence generation will be best positioned to capture new opportunities. Cross-border collaboration and adaptive regulatory engagement will accelerate commercialization, ultimately improving patient outcomes and unlocking sustainable growth. The insights presented here form a blueprint for navigating uncertainty and charting a course toward continued innovation in neurology care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Growth and integration of AI-enabled portable EEG wearables for continuous home epilepsy monitoring
  • 5.2. Advances in closed-loop deep brain stimulation devices offering adaptive therapy for Parkinson's disease management
  • 5.3. Rising adoption of noninvasive transcranial magnetic stimulation devices for treatment-resistant major depressive disorder
  • 5.4. Emergence of implantable wireless neurostimulation systems with smartphone connectivity for chronic neuropathic pain relief
  • 5.5. Development of high-density intracortical electrode arrays enabling real-time brain-computer interface control in paralysis rehabilitation
  • 5.6. Expansion of miniaturized wearable near-infrared spectroscopy devices for noninvasive monitoring in stroke recovery programs

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Neurology Devices Market, by Product

  • 8.1. Introduction
  • 8.2. CSF Management Devices
    • 8.2.1. Cerebral External Drainage
    • 8.2.2. Cerebral Shunts
  • 8.3. Interventional Neurology
    • 8.3.1. Aneurysm Coiling and Embolization
      • 8.3.1.1. Embolic Coils
      • 8.3.1.2. Flow Diversion Devices
      • 8.3.1.3. Liquid Embolic Reagents
    • 8.3.2. Cerebral Balloon Angioplasty & Stents
      • 8.3.2.1. Balloon Occlusion Devices
      • 8.3.2.2. Carotid Artery Stents
      • 8.3.2.3. Filter Devices
    • 8.3.3. Neurothromobectomy
      • 8.3.3.1. Clot Retrievers
      • 8.3.3.2. Snare Devices
      • 8.3.3.3. Suction Aspiration Devices
    • 8.3.4. Neurovascular Catheters
  • 8.4. Neurostimulation
    • 8.4.1. Deep Brain Stimulation
    • 8.4.2. Gastric Electric Stimulation
    • 8.4.3. Sacral Nerve Stimulation
    • 8.4.4. Spinal Cord Stimulation
    • 8.4.5. Vagus Nerve Stimulation
  • 8.5. Neurosurgery Devices
    • 8.5.1. Aneurysm Clips
    • 8.5.2. Neuroendoscopes
    • 8.5.3. Stereotactic Systems
    • 8.5.4. Ultrasonic Aspirators

9. Neurology Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Chronic Pain
  • 9.3. Epilepsy & Seizure Disorders
    • 9.3.1. Diagnosis & Monitoring of Epilepsy
    • 9.3.2. Seizure Control Devices
  • 9.4. Mental Health Disorders
    • 9.4.1. Anxiety
    • 9.4.2. Depression
    • 9.4.3. Schizophrenia
  • 9.5. Multiple Sclerosis (MS)
  • 9.6. Neurodegenerative Disorders
    • 9.6.1. Alzheimer's Disease
    • 9.6.2. Amyotrophic Lateral Sclerosis (ALS)
    • 9.6.3. Huntington's Disease
    • 9.6.4. Parkinson's Disease
  • 9.7. Neurovascular Disorders
  • 9.8. Spinal Cord Injuries
  • 9.9. Stroke
    • 9.9.1. Hemorrhagic Stroke Devices
    • 9.9.2. Ischemic Stroke Devices
    • 9.9.3. Stroke Rehabilitation Devices
  • 9.10. Traumatic Brain Injury (TBI)

10. Neurology Devices Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Diagnostic Centers
  • 10.4. Home Care
  • 10.5. Hospitals
  • 10.6. Neurology Clinics
  • 10.7. Rehabilitation Centers

11. Neurology Devices Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Offline
  • 11.3. Online

12. Americas Neurology Devices Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Neurology Devices Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Neurology Devices Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Abbott Laboratories
    • 15.3.2. Acandis GmbH
    • 15.3.3. B. Braun SE
    • 15.3.4. Boston Scientific Corporation
    • 15.3.5. Esaote SpA
    • 15.3.6. GE HealthCare Technologies, Inc.
    • 15.3.7. Integra LifeSciences Holdings
    • 15.3.8. Koninklijke Philips N.V.
    • 15.3.9. Masimo Corporation
    • 15.3.10. Medtronic PLC
    • 15.3.11. MicroPort Scientific Corporation
    • 15.3.12. Natus Medical Inc.
    • 15.3.13. Nihon Kohden Corporation
    • 15.3.14. Penumbra Inc.
    • 15.3.15. Rapid Medical Ltd.
    • 15.3.16. Siemens Healthcare GmbH
    • 15.3.17. Stryker Corporation
    • 15.3.18. Terumo Corporation

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. NEUROLOGY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. NEUROLOGY DEVICES MARKET: RESEARCHAI
  • FIGURE 24. NEUROLOGY DEVICES MARKET: RESEARCHSTATISTICS
  • FIGURE 25. NEUROLOGY DEVICES MARKET: RESEARCHCONTACTS
  • FIGURE 26. NEUROLOGY DEVICES MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. NEUROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEUROLOGY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL EXTERNAL DRAINAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL EXTERNAL DRAINAGE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL SHUNTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL SHUNTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERSION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY LIQUID EMBOLIC REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY LIQUID EMBOLIC REAGENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY BALLOON OCCLUSION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY BALLOON OCCLUSION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FILTER DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY FILTER DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SNARE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SNARE DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SUCTION ASPIRATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SUCTION ASPIRATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR CATHETERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY GASTRIC ELECTRIC STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY GASTRIC ELECTRIC STIMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM CLIPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM CLIPS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROENDOSCOPES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STEREOTACTIC SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ULTRASONIC ASPIRATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSIS & MONITORING OF EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSIS & MONITORING OF EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SEIZURE CONTROL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SEIZURE CONTROL DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANXIETY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ANXIETY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS (MS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY MULTIPLE SCLEROSIS (MS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS (ALS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS (ALS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HUNTINGTON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HUNTINGTON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 119. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD INJURIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY SPINAL CORD INJURIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 121. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 123. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HEMORRHAGIC STROKE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HEMORRHAGIC STROKE DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 125. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 127. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE REHABILITATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE REHABILITATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 129. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
  • TABLE 131. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY TRAUMATIC BRAIN INJURY (TBI), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 133. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 135. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 137. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 139. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 141. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 143. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 145. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 147. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 149. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 151. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEUROLOGY DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 153. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 155. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 157. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 159. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 161. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 163. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 165. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 167. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 169. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 171. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 173. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 175. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 177. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
  • TABLE 179. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 181. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 183. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 185. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 187. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 189. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 191. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 192. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 193. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 194. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 197. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 198. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 199. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 200. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 201. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 203. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 204. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 205. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 206. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 207. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 209. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
  • TABLE 211. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 213. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 215. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 216. UNITED STATES NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 217. CANADA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 218. CANADA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 219. CANADA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 220. CANADA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 221. CANADA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 222. CANADA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 223. CANADA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 224. CANADA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 225. CANADA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 226. CANADA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 227. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 228. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 229. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 230. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 231. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 232. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 233. CANADA NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. CANADA NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. CANADA NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 236. CANADA NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 237. CANADA NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 238. CANADA NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 239. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 240. CANADA NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 241. CANADA NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
  • TABLE 242. CANADA NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
  • TABLE 243. CANADA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. CANADA NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 245. CANADA NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. CANADA NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 247. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 249. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 250. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 251. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 253. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 255. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 256. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 257. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 258. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 259. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 260. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 261. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 263. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 265. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 266. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 267. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 268. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 269. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 270. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 271. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
  • TABLE 272. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
  • TABLE 273. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 275. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 276. MEXICO NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 277. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 278. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 279. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 280. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 281. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 283. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 284. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 285. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 286. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 287. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 288. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 289. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 290. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 291. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 292. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 293. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 295. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 296. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY EPILEPSY & SEIZURE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 297. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 298. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY MENTAL HEALTH DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 299. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 300. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2025-2030 (USD MILLION)
  • TABLE 301. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2018-2024 (USD MILLION)
  • TABLE 302. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY STROKE, 2025-2030 (USD MILLION)
  • TABLE 303. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 305. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. BRAZIL NEUROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 307. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 308. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
  • TABLE 309. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 310. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY CSF MANAGEMENT DEVICES, 2025-2030 (USD MILLION)
  • TABLE 311. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL NEUROLOGY, 2025-2030 (USD MILLION)
  • TABLE 313. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2018-2024 (USD MILLION)
  • TABLE 314. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM COILING AND EMBOLIZATION, 2025-2030 (USD MILLION)
  • TABLE 315. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2018-2024 (USD MILLION)
  • TABLE 316. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL BALLOON ANGIOPLASTY & STENTS, 2025-2030 (USD MILLION)
  • TABLE 317. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2018-2024 (USD MILLION)
  • TABLE 318. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROTHROMOBECTOMY, 2025-2030 (USD MILLION)
  • TABLE 319. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2024 (USD MILLION)
  • TABLE 320. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2025-2030 (USD MILLION)
  • TABLE 321. ARGENTINA NEUROLOGY DEVICES MARKET SIZE, BY NEUROSURGERY DEVICES, 2018-2024 (US